期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

黏菌素神经毒性的研究进展 被引量：3

Review on the Neurotoxicity of Colistin
下载PDF
导出
摘要 系统回顾了黏菌素神经毒性的发生情况、主要症状、作用机制、神经毒性反应的危险因素以及神经毒性的预防与治疗,为期为神经毒性研究以及临床用药提供参考资料。 In this paper,the mechanisms,incidence,clinical manifestations,risk factors,treatment and prevention of the colistin neurotoxicity were systematically reviewed in order to provide some reference for the neurotoxicity research and rational drug usage in clinic.
作者 代重山 李继昌 林巍 孙美成 李健
机构地区 东北农业大学动物医学学院 澳大利亚蒙纳士大学药学院FADDI研究室
出处 《中国兽药杂志》 2012年第5期54-57,共4页 Chinese Journal of Veterinary Drug
基金 黑龙江省留学生归国科学基金(LC201018) 教育部留学回国人员科研启动基金(No.41)
关键词 黏菌素 神经毒性 机制 发生情况 症状 危险因素 colistin neurotoxicity mechanisms incidence clinical manifestations risk factors
分类号 S859.8 [农业科学—临床兽医学]
  • 相关文献

参考文献31

  • 1Gobin P,Lemaltre F,Marehand S. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chroma- tography - tandem mass spectrometry[J].Antimicrobial Agents and Chemotherapy,2010,(05):1941-1948.
  • 2Bergen P J,Li J,Rayner C R. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa[J].Antimicrobial Agents and Chemotherapy,2006,(06):1953-1958.
  • 3Falagas M E,Kasiakou S K. Colistin:The revival of polymyxins for the management of multidrug - resistant gram - negative bacterial infections[J].Clinical Infectious Diseases,2005,(09):1333-1341.
  • 4Falagas M E,Kasiakou S K,Tsiodras S. The use of intra venous and aerosolized polymyxins for the treatment of infections in critically ill patients:A review of the recent literature[J].Clinical Medicine and Research,2006,(02):138-146.
  • 5Nation R L,Li J. Colistin in the 21st[J].Century Curr Opin Infect Dis,2009,(06):535-543.
  • 6Lim L M,Ly N,Anderson D. Resurgence of colistin:A review of resistance,toxicity,pharmaeodynamics,and dosing[J].Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy,2010,(12):1279-1291.
  • 7Li J,Roger L N,John D T. Colistin :The re - emerging antibiotic for multidrug - resistant gram - negative bacterial infec- tions[J].Lancet Infectious Diseases,2006.589-601.
  • 8陈杖榴.兽医药理学[M]北京:中国农业出版社,2002.
  • 9韩振兴,李继昌,蒋国政,刘挺,王凤霞.黏杆菌素对两种诱导多重耐药革兰氏阴性杆菌的体外抗菌活性[J].中国兽医科学,2011,41(11):1202-1205. 被引量：3
  • 10Koch - Weser J,Sidel V W,Federman E B. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy[J].Annals of Internal Medicine,1970,(06):857-868.

二级参考文献20

  • 1LI J, NATION R L, TURNIDGE J D, etal. Colistin:the re- emerging antibiotic for multidrug-resistant Gram-negative bae terial infeetions[J]. Lancet Infect Dis, 2006,6 (9) : 589-601.
  • 2KOCH-WESER J, SIDDEL V W, FEDERMAN E B, et al.Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy[J]. Ann Intern Med ,1970,72(6) :857-868.
  • 3OBRITSCH M D, FISH D N,MACLAREN R,et al. Nosoco- mial infection due to multidrug-resistant Pseudomonas aerugi- nosa =epidemiology and treatment option[J]. Pharmacothera- py, 2005,25 (10) : 1353-1364.
  • 4RODRIGUEZ C H, PAUTASO J, BOMBICINO K,et al. Sen- sitivity to colistin:evaluation of cut-off points available in disk diffusion test[J]. RevArgent Microbio1,2004,36(3) : 125-129.
  • 5TAN T ,NG L S. Comparison of three standardized disc sus ceptibility testing methods for eolisti[J]. J Antimicrob Che- mother, 2006,58(4) ,864 867.
  • 6Clinical and Laboratory Standards Institute/NCCLS. M7 A7 Methods for dilution antimicrobial susceptibility tests for bac teria that grow aerobically. 7. CLSI approved standard[S] PA, Wayne, 2006.
  • 7Clinical and Laboratory Standards Institute/NCCLS. M100 S15. Performance standards for antimicrobial susceptibility testing. 16th informational supplement CLSI document[S]. PA, Wayne, 2006.
  • 8MICHEA-HAMZEHPOUR M,KAHR A,PECHERE J C. In vitro stepwise selection of resistance to quinolones,lactams and amikacin in nosocomial Gram-negative baeilli[J]. Infec tion,1994,22(Suppl. 2) :105 110.
  • 9PETERSEN P J,JONES C H,BRADFORD P A. In vitro anti- bacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller Hinton broth[J]. Diagn Microbiol Infect Dis, 2007,59(3) : 347-349.
  • 10LI J, NATION R L, MILNE R W, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Int J Antimicrob Agents, 2005,25(1) :11-25.

共引文献13

同被引文献43

  • 1陈国江,王建安,韩根成,王仁喜,宋伦,池木根,沈倍奋,黎燕.重症肌无力小鼠模型的建立[J].中国实验动物学报,2006,14(1):59-62. 被引量：2
  • 2温芳,肖希龙.鸡组织中硫酸粘杆菌素残留的微生物学检测方法研究[J].中国兽药杂志,2006,40(7):29-33. 被引量：8
  • 3周艳,方静,李英伦.粘杆菌素研究及其应用[J].中国饲料,2006(16):15-17. 被引量：17
  • 4Landman D, Georgeseu C, Martin D A, et al. Polymyxins revisited [J]. Clin Microbiol Rev, 2008, 21(3): 449-465.
  • 5Lim L M, Ly N, Anderson D, Yang J C, et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing[J]. Pharmacotherapy, 2010, 30: 1279-1291.
  • 6Bosso J A, Liptak C A, Seilheimer D K, et al. Toxicity of colistin in cystic fibrosis patients[J]. Ann Pharmacother, 1991, 25(11): 1168-1170.
  • 7Falagas M E, Kasiakou S K. Toxicity of polymyxins: A systematic review of the evidence from old and recent studies[J]. Crit Care, 2006, 10: R27.
  • 8Dai C, Li J, Lin W, et al. Electrophysiology and ultrastructural changes in mouse sciatic nerve associated with colistin Sulfate exposure [J]. Toxicol Mech Methods, 2012, 22(8): 592-596.
  • 9Lehning E J, Jortner B S, Fox J H, et al. Gamma-diketone peripheral neuropathy. I. Quality morphometfic analyses of axonal atrophy and swelling[J]. Toxicol Appl Pharmacol, 2000, 165(2): 127-140.
  • 10Krutki P, Ciechanowicz I, Celichowski J, et al. Comparative analysis of motor unit action potentials of the medial gastrocnemius muscle in cats and rats[J]. J Electromyogr Kinesiol, 2008, 18(5): 732-740.

引证文献3

二级引证文献8

中国兽药杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部